Annual Operating Expenses
$134.26 M
-$143.58 M-51.68%
31 December 2023
Summary:
Inovio Pharmaceuticals annual total operating expenses is currently $134.26 million, with the most recent change of -$143.58 million (-51.68%) on 31 December 2023. During the last 3 years, it has risen by +$2.77 million (+2.10%). INO annual operating expenses is now -55.69% below its all-time high of $302.99 million, reached on 31 December 2021.INO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$27.35 M
-$5.95 M-17.87%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly total operating expenses is currently $27.35 million, with the most recent change of -$5.95 million (-17.87%) on 30 September 2024. Over the past year, it has increased by +$1.92 million (+7.55%). INO quarterly operating expenses is now -74.28% below its all-time high of $106.35 million, reached on 31 December 2021.INO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.7% | +7.5% |
| 3 y3 years | +2.1% | -54.6% |
| 5 y5 years | +7.8% | +10.2% |
INO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -55.7% | +2.1% | -74.3% | +7.5% |
| 5 y | 5 years | -55.7% | +16.5% | -74.3% | +10.2% |
| alltime | all time | -55.7% | +2119.0% | -74.3% | +5500.6% |
Inovio Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $27.35 M(-17.9%) |
| June 2024 | - | $33.30 M(+5.8%) |
| Mar 2024 | - | $31.48 M(+14.5%) |
| Dec 2023 | $134.26 M(-51.7%) | $27.50 M(+8.1%) |
| Sept 2023 | - | $25.43 M(-31.8%) |
| June 2023 | - | $37.27 M(-15.4%) |
| Mar 2023 | - | $44.07 M(-21.4%) |
| Dec 2022 | $277.84 M(-8.3%) | $56.07 M(+24.8%) |
| Sept 2022 | - | $44.91 M(-57.2%) |
| June 2022 | - | $104.92 M(+45.9%) |
| Mar 2022 | - | $71.93 M(-32.4%) |
| Dec 2021 | $302.99 M(+130.4%) | $106.35 M(+76.5%) |
| Sept 2021 | - | $60.24 M(-27.8%) |
| June 2021 | - | $83.47 M(+57.7%) |
| Mar 2021 | - | $52.93 M(+51.6%) |
| Dec 2020 | $131.49 M(+14.1%) | $34.92 M(-4.5%) |
| Sept 2020 | - | $36.57 M(+9.3%) |
| June 2020 | - | $33.45 M(+25.9%) |
| Mar 2020 | - | $26.56 M(-13.5%) |
| Dec 2019 | $115.22 M(-7.5%) | $30.70 M(+23.7%) |
| Sept 2019 | - | $24.82 M(-12.4%) |
| June 2019 | - | $28.34 M(-9.7%) |
| Mar 2019 | - | $31.36 M(-2.0%) |
| Dec 2018 | $124.57 M(-1.8%) | $32.00 M(+11.7%) |
| Sept 2018 | - | $28.64 M(-3.4%) |
| June 2018 | - | $29.65 M(-13.5%) |
| Mar 2018 | - | $34.28 M(+4.9%) |
| Dec 2017 | $126.86 M(+12.7%) | $32.67 M(+2.7%) |
| Sept 2017 | - | $31.83 M(+5.9%) |
| June 2017 | - | $30.05 M(-7.0%) |
| Mar 2017 | - | $32.31 M(+4.6%) |
| Dec 2016 | $112.60 M(+48.4%) | $30.88 M(-5.7%) |
| Sept 2016 | - | $32.74 M(+28.7%) |
| June 2016 | - | $25.43 M(+7.9%) |
| Mar 2016 | - | $23.56 M(+15.1%) |
| Dec 2015 | $75.86 M(+51.9%) | $20.46 M(+0.0%) |
| Sept 2015 | - | $20.45 M(-4.5%) |
| June 2015 | - | $21.41 M(+58.2%) |
| Mar 2015 | - | $13.53 M(+0.5%) |
| Dec 2014 | $49.95 M(+42.7%) | $13.47 M(+32.4%) |
| Sept 2014 | - | $10.17 M(-27.1%) |
| June 2014 | - | $13.95 M(+12.9%) |
| Mar 2014 | - | $12.36 M(+15.0%) |
| Dec 2013 | $35.01 M(+21.7%) | $10.74 M(+23.2%) |
| Sept 2013 | - | $8.72 M(+16.9%) |
| June 2013 | - | $7.46 M(-7.8%) |
| Mar 2013 | - | $8.09 M(+9.9%) |
| Dec 2012 | $28.76 M(-10.2%) | $7.36 M(-3.7%) |
| Sept 2012 | - | $7.65 M(+5.9%) |
| June 2012 | - | $7.22 M(+10.6%) |
| Mar 2012 | - | $6.53 M(-11.9%) |
| Dec 2011 | $32.02 M | $7.41 M(-20.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $9.31 M(+23.2%) |
| June 2011 | - | $7.56 M(-2.4%) |
| Mar 2011 | - | $7.74 M(+1.3%) |
| Dec 2010 | $25.36 M(+9.9%) | $7.64 M(+31.0%) |
| Sept 2010 | - | $5.83 M(-4.5%) |
| June 2010 | - | $6.11 M(+5.7%) |
| Mar 2010 | - | $5.78 M(-10.0%) |
| Dec 2009 | $23.08 M(+46.5%) | $6.42 M(-11.3%) |
| Sept 2009 | - | $7.24 M(+32.1%) |
| June 2009 | - | $5.48 M(+39.5%) |
| Mar 2009 | - | $3.93 M(+3.7%) |
| Dec 2008 | $15.76 M(-23.9%) | $3.79 M(+18.3%) |
| Sept 2008 | - | $3.20 M(-32.8%) |
| June 2008 | - | $4.77 M(+19.2%) |
| Mar 2008 | - | $4.00 M(-22.1%) |
| Dec 2007 | $20.71 M(+23.1%) | $5.13 M(-6.9%) |
| Sept 2007 | - | $5.51 M(+5.0%) |
| June 2007 | - | $5.25 M(+9.3%) |
| Mar 2007 | - | $4.81 M(-9.7%) |
| Dec 2006 | $16.81 M(-4.7%) | $5.33 M(+29.5%) |
| Sept 2006 | - | $4.11 M(+6.4%) |
| June 2006 | - | $3.87 M(+10.1%) |
| Mar 2006 | - | $3.51 M(-9.9%) |
| Dec 2005 | $17.64 M(+39.2%) | $3.90 M(+3.7%) |
| Sept 2005 | - | $3.76 M(-26.8%) |
| June 2005 | - | $5.14 M(+5.9%) |
| Mar 2005 | - | $4.85 M(+9.5%) |
| Dec 2004 | $12.68 M(+88.8%) | $4.43 M(+10.8%) |
| Sept 2004 | - | $4.00 M(+55.8%) |
| June 2004 | - | $2.56 M(+52.1%) |
| Mar 2004 | - | $1.69 M(-8.7%) |
| Dec 2003 | $6.71 M(+9.6%) | $1.85 M(+7.3%) |
| Sept 2003 | - | $1.72 M(+22.1%) |
| June 2003 | - | $1.41 M(-19.8%) |
| Mar 2003 | - | $1.76 M(+15.7%) |
| Dec 2002 | $6.12 M(+1.2%) | $1.52 M(-1.4%) |
| Sept 2002 | - | $1.54 M(-1.5%) |
| June 2002 | - | $1.56 M(+4.4%) |
| Mar 2002 | - | $1.50 M(-38.1%) |
| Dec 2001 | $6.05 M(-36.9%) | - |
| Sept 2001 | - | $2.42 M(-24.7%) |
| June 2001 | - | $3.21 M(+557.3%) |
| Mar 2001 | - | $488.30 K(-84.5%) |
| Mar 2001 | $9.58 M(-27.1%) | - |
| Dec 2000 | - | $3.14 M(+3.4%) |
| Sept 2000 | - | $3.04 M(+3.4%) |
| June 2000 | - | $2.94 M(-14.9%) |
| Mar 2000 | $13.15 M(-6.0%) | $3.45 M(+27.9%) |
| Dec 1999 | - | $2.70 M(-15.6%) |
| Sept 1999 | - | $3.20 M(-13.5%) |
| June 1999 | - | $3.70 M(-2.6%) |
| Mar 1999 | $14.00 M | $3.80 M(-2.6%) |
| Dec 1998 | - | $3.90 M |
FAQ
- What is Inovio Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual operating expenses year-on-year change?
- What is Inovio Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly operating expenses year-on-year change?
What is Inovio Pharmaceuticals annual total operating expenses?
The current annual operating expenses of INO is $134.26 M
What is the all time high annual operating expenses for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual total operating expenses is $302.99 M
What is Inovio Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, INO annual total operating expenses has changed by -$143.58 M (-51.68%)
What is Inovio Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of INO is $27.35 M
What is the all time high quarterly operating expenses for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly total operating expenses is $106.35 M
What is Inovio Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, INO quarterly total operating expenses has changed by +$1.92 M (+7.55%)